Woodline Partners’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.4M | Sell |
1,897,197
-545,200
| -22% | -$9.87M | 0.18% | 157 |
|
|
2025
Q1 | $50M | Buy |
2,442,397
+11,615
| +0.5% | +$238K | 0.33% | 83 |
|
|
2024
Q4 | $62.5M | Buy |
2,430,782
+1,266,105
| +109% | +$32.5M | 0.42% | 53 |
|
|
2024
Q3 | $19.3M | Buy |
1,164,677
+681,289
| +141% | +$11.3M | 0.16% | 195 |
|
|
2024
Q2 | $9.29M | Buy |
+483,388
| New | +$9.29M | 0.09% | 255 |
|